Home > Research > Publications & Outputs > Identification of novel inhibitors of UDP-Glc 4...
View graph of relations

Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness

Research output: Contribution to Journal/MagazineJournal articlepeer-review

  • Michael D. Urbaniak
  • Jioji N. Tabudravu
  • Aichi Msaki
  • Kathy Mansfield Matera
  • Ruth Brenk
  • Marcel Jaspars
  • Michael A. J. Ferguson
<mark>Journal publication date</mark>15/11/2006
<mark>Journal</mark>Bioorganic and Medicinal Chemistry Letters
Issue number22
Number of pages4
Pages (from-to)5744-5747
Publication StatusPublished
<mark>Original language</mark>English


Novel inhibitors of Trypanosoma brucei and mammalian UDP-Glc 4'-epimerase were identified by screening a small library of natural products and commercially available drug-like molecules. The inhibitors possess low micromolar potency against the T. brucei and human enzymes in vitro, display a degree of selectivity between the two enzymes, and are cytotoxic to cultured T. brucei and mammalian cells.